Immunology

Version vom 6. Juni 2020, 05:55 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

• rev. on covid immunology

32364527 2020. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
32282871 ä. Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19)
32371101 ä. The correlation between SARS-CoV-2 infection and rheumatic disease
32205186 2020. COVID-19 infection and rheumatoid arthritis: Faraway, so close!
32308263 2020. CoViD-19 Immunopathology and Immunotherapy
32325421 2020. Increased expression of CD8 marker on T-cells in COVID-19 patients
32205856 2020. COVID-19 infection: the perspectives on immune responses
32359396 ä. A Dynamic Immune Response Shapes COVID-19 Progression
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
32320677 ä. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
32346099 ä. High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients

32339487 2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China
32333860 2020. Presepsin in risk stratification of SARS-CoV-2 patients
32161940 ä. Dysregulation of immune response in patients with COVID-19 in Wuhan, China
32280952 ä. Good IgA bad IgG in SARS-CoV-2 infection?
32354367 2020. Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia

32361250 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
32368728 ä. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study
32228226 2020. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients
32196410 2020. Hypothesis for potential pathogenesis of SARS-CoV-2 infection?a review of immune changes in patients with viral pneumonia
32172672 2020. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses

32348472 ä. A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients?

32360285 ä. Type I IFN immunoprofiling in COVID-19 patients
32344056 ä. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination
32333914 ä. A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia
32344321 2020. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19
32344320 ä. The clinical course and its correlated immune status in COVID-19 pneumonia
32353870 2020. The many faces of the anti-COVID immune response

32277967 ä. SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19)
32325129 ä. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia
32315725 ä. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China
32283159 ä. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
32283164 ä. Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China
32283162 ä. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19
32358956 ä. Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19

32227123 ä. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia

31981224 2020. Coronavirus infections and immune responses
32198005 2020. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic
32282863 ä. Molecular immune pathogenesis and diagnosis of COVID-19

32292901 2020. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity
32303592 2020. Human leukocyte antigen susceptibility map for SARS-CoV-2
32215589 2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia
32324595 2020. The laboratory tests and host immunity of COVID-19 patients with different severity of illness

32259560 ä. Interleukin-6 as a potential biomarker of COVID-19 progression

32268188 ä. It is too soon to attribute ADE to COVID-19
32361001 ä. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes

32248387 ä. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution
32321823 2020. COVID-19: an Immunopathological View
32284614 ä. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
32273594 ä. COVID-19: immunopathology and its implications for therapy
32249845 ä. Fighting COVID-19 exhausts T cells
32355329 ä. SARS-CoV-2-reactive T cells in patients and healthy donors

32346093 ä. The trinity of COVID-19: immunity, inflammation and intervention
32346091 ä. Neutralizing antibody response in mild COVID-19
32303697 ä. Will we see protection or reinfection in COVID-19?
32303696 ä. Macrophages: a Trojan horse in COVID-19?

32343510 2020. COVID-19: are T lymphocytes simply watching?
32340873 ä. Reply: Thymopoiesis, inflamm-aging, and COVID-19 phenotype
32317217 ä. Role of thymopoiesis and inflamm-aging in COVID-19 phenotype

32315421 ä. Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19)

32292530 2020. Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan

32369190 2020. COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series
32298486 2020. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19)
32360743 ä. Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19

32220633 2020. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?
32297671 2020. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients
32311762 2020. SARS-CoV-2: a new aetiology for atypical lymphocytes
32297330 2020. Reactive lymphocytes in patients with Covid-19

32375560 2020. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study

32119647 2020. Laboratory abnormalities in patients with COVID-2019 infection
32172227 2020. Laboratory abnormalities in children with novel coronavirus disease 2019
32352397 2020. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study
32242828 2020. Decreased "WBC*LYM" was observed in SARS-CoV-2-infected patients from a fever clinic in Wuhan
32301746 2020. Routine blood tests as a potential diagnostic tool for COVID-19

32365221 2020. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19
32315487 2020. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19
32343152 2020. ABO blood group predisposes to COVID-19 severity and cardiovascular diseases
32376308 ä. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis

32379887 ä. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19
32181911 ä. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID?19
32356908 2020. Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis
32347972 2020. Elevations of serum cancer biomarkers correlate with severity of COVID-19
32343415 2020. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients
32297995 2020. High IL-6/IFN-gamma ratio could be associated with severe disease in COVID-19 patients
32281668 2020. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early

32376901 ä. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
32348636 2020. Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva

32330332 2020. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic
32379199 2020. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes
32267987 2020. Immune responses and pathogenesis of SARS?CoV?2 during an outbreak in Iran: Comparison with SARS and MERS
32296069 2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

32348715 2020. B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020
32297828 2020. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19
32370466 2020. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19
32114745 2020. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19

32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
32407669 ä. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
32382126 ä. Protective humoral immunity in SARS-CoV-2 infected pediatric patients
32382127 ä. NKG2A and COVID-19: another brick in the wall we dont need no isolation we dont need no folks control
32235915 ä. COVID-19: a new challenge for human beings

32132669 ä. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
C7064018 ä. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses